Genetic correction of haemoglobin E in an immortalised haemoglobin E/beta-thalassaemia cell line using the CRISPR/Cas9 system
β-thalassaemia is one of the most common genetic blood diseases worldwide with over 300 mutations in the HBB gene affecting red blood cell functions. Recently, advances in genome editing technology have provided a powerful tool for precise genetic correction. Generation of patient-derived induced pl...
Saved in:
Main Author: | Trakarnsanga K. |
---|---|
Other Authors: | Mahidol University |
Format: | Article |
Published: |
2023
|
Subjects: | |
Online Access: | https://repository.li.mahidol.ac.th/handle/123456789/86393 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | Mahidol University |
Similar Items
-
Cardiac pathology in 47 patients with beta thalassaemia/haemoglobin E
by: D. Sonakul, et al.
Published: (2018) -
Haemoglobin E β thalassaemia in Sri Lanka
by: A. Premawardhena, et al.
Published: (2018) -
One-step genetic correction of hemoglobin E/beta-thalassemia patient-derived iPSCs by the CRISPR/Cas9 system
by: Methichit Wattanapanitch, et al.
Published: (2019) -
Genetics of haemoglobin H and α‐thalassaemia
by: R. D. KOLER, et al.
Published: (2018) -
Increased erythrocyte superoxide dismutase activities in β° -thalassaemia/haemoglobin E and in haemoglobin H diseases
by: P. Yenchitsomanus, et al.
Published: (2018)